Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Rossi

Showing results (121-130 of 173) with videos related to

Pageof 18
Sort By:
Leukemia & Lymphoma|April 4, 2013
Minimal residual disease after allogeneic stem cell transplant: a comparison among multiparametric flow cytometry, Wilms tumor 1 expression and chimerism status (Complete chimerism versus Low Level Mixed Chimerism) in acute leukemiaGiovanni Rossi, Angelo Michele Carella, Maria Marta Minervini, et al.
Mediterranean Journal of Hematology and Infectious Diseases|September 14, 2012
Regulatory T-cells in chronic lymphocytic leukemia and autoimmune diseasesGiovanni D'Arena, Giovanni Rossi, Barbara Vannata, et al.
Plos One|September 17, 2015
Universal Principles in the Repair of Communication ProblemsMark Dingemanse, Seán G Roberts, Julija Baranova, et al.
International Journal of Antimicrobial Agents|February 4, 2021
Rifampicin and Isoniazid Maximal Concentrations are Below Efficacy-associated Thresholds in the Majority of Patients: Time to Increase the Doses?Alice Trentalange, Enrica Borgogno, Ilaria Motta, et al.
Vaccines|October 26, 2021
Associations between Allelic Variants of the Human IgH 3' Regulatory Region 1 and the Immune Response to BNT162b2 mRNA VaccineMattia Colucci, Elisabetta De Santis, Beatrice Totti, et al.
The Oncologist|March 24, 2018
Serial Troponin for Early Detection of Nivolumab Cardiotoxicity in Advanced Non-Small Cell Lung Cancer PatientsMatteo Sarocchi, Francesco Grossi, Eleonora Arboscello, et al.
Expert Opinion on Biological Therapy|August 22, 2022
Immunotherapy-chemotherapy combinations for non-small cell lung cancer: current trends and future perspectivesEugenia Cella, Lodovica Zullo, Silvia Marconi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 7, 2019
Comparison Between <sup>18</sup>F-FDG PET-Based and CT-Based Criteria in Non-Small Cell Lung Cancer Patients Treated with NivolumabGiovanni Rossi, Matteo Bauckneht, Carlo Genova, et al.
Journal of Clinical Medicine|July 13, 2019
Prognostic Relevance of Circulating Tumor Cells and Circulating Cell-Free DNA Association in Metastatic Non-Small Cell Lung Cancer Treated with NivolumabAngela Alama, Simona Coco, Carlo Genova, et al.
Cytometry. Part B, Clinical Cytometry|December 15, 2018
Minimal residual disease and log-reduction of plasma cells are associated with superior response after double autologous stem cell transplant in younger patients with multiple myelomaGiovanni Rossi, Antonietta Pia Falcone, Maria Marta Minervini, et al.
Pageof 18

Showing results (121-130 of 173) with videos related to

Sort By:
Pageof 18
Leukemia & Lymphoma|April 4, 2013
Minimal residual disease after allogeneic stem cell transplant: a comparison among multiparametric flow cytometry, Wilms tumor 1 expression and chimerism status (Complete chimerism versus Low Level Mixed Chimerism) in acute leukemiaGiovanni Rossi, Angelo Michele Carella, Maria Marta Minervini, et al.
Mediterranean Journal of Hematology and Infectious Diseases|September 14, 2012
Regulatory T-cells in chronic lymphocytic leukemia and autoimmune diseasesGiovanni D'Arena, Giovanni Rossi, Barbara Vannata, et al.
Plos One|September 17, 2015
Universal Principles in the Repair of Communication ProblemsMark Dingemanse, Seán G Roberts, Julija Baranova, et al.
International Journal of Antimicrobial Agents|February 4, 2021
Rifampicin and Isoniazid Maximal Concentrations are Below Efficacy-associated Thresholds in the Majority of Patients: Time to Increase the Doses?Alice Trentalange, Enrica Borgogno, Ilaria Motta, et al.
Vaccines|October 26, 2021
Associations between Allelic Variants of the Human IgH 3' Regulatory Region 1 and the Immune Response to BNT162b2 mRNA VaccineMattia Colucci, Elisabetta De Santis, Beatrice Totti, et al.
The Oncologist|March 24, 2018
Serial Troponin for Early Detection of Nivolumab Cardiotoxicity in Advanced Non-Small Cell Lung Cancer PatientsMatteo Sarocchi, Francesco Grossi, Eleonora Arboscello, et al.
Expert Opinion on Biological Therapy|August 22, 2022
Immunotherapy-chemotherapy combinations for non-small cell lung cancer: current trends and future perspectivesEugenia Cella, Lodovica Zullo, Silvia Marconi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 7, 2019
Comparison Between <sup>18</sup>F-FDG PET-Based and CT-Based Criteria in Non-Small Cell Lung Cancer Patients Treated with NivolumabGiovanni Rossi, Matteo Bauckneht, Carlo Genova, et al.
Journal of Clinical Medicine|July 13, 2019
Prognostic Relevance of Circulating Tumor Cells and Circulating Cell-Free DNA Association in Metastatic Non-Small Cell Lung Cancer Treated with NivolumabAngela Alama, Simona Coco, Carlo Genova, et al.
Cytometry. Part B, Clinical Cytometry|December 15, 2018
Minimal residual disease and log-reduction of plasma cells are associated with superior response after double autologous stem cell transplant in younger patients with multiple myelomaGiovanni Rossi, Antonietta Pia Falcone, Maria Marta Minervini, et al.
Pageof 18